Outset is the preferred lead investor of deep tech deals in New Zealand. Our competitive advantage lies in the unique intersection of Team, Facilities and Networks. Our deeply experienced people and 50,000ft2 of research and development facilities, allow unrivalled access to early stage science and engineering ventures.
Since late 2020, we have been actively engaged in investing, carefully selecting 23 portfolio companies. With 80% of our funds already deployed, we have successfully positioned ourselves to anchor the promising Fund II pipeline.
Zincovery
Aspiring
Material
Hot Lime Labs
Daisy Lab
NewFish
Reactory
Ceryx Medical
Toku Eyes
Heartlab
Wellumio
Open Star
Energy Bank
Vertus Energy
Aquila
Osho
Red Phase
Foundry Lab
RespirAq
Dennisson
Technologies
Astrix Astronautics
PyperVision
TransAxon
Helico Bio
Want to know more about Outset and Fund II?